Literature DB >> 34325

Determination of liver intracellular pH in vivo and its homeostasis in acute acidosis and alkalosis.

R Park, W J Leach, A I Arieff.   

Abstract

An in vivo method is presented for the determination of liver intracellular pH (pHi) using [14C]dimethadione (DMO) in dogs. This method differs from those previously published in that hepatic venous and portal venous blood pH were selected as the extracellular reference pH, and liver blood space corrections are applied to whole liver tissue [14C]DMO activity. Using these corrections, a normal liver pHi of 6.99 +/- 0.03 (SE) was obtained. During acute metabolic acidosis and alkalosis, as well as during acute respiratory acidosis and alkalosis, the liver pHi remained normal; metabolic acidosis was 7.04 +/- 0.04; metabolic alkalosis was 6.92 +/- 0.08; respiratory acidosis was 6.98 +/- 0.04; and respiratory alkalosis was 7.00 +/- 0.10. None of these values was significantly different from normal (P greater than 0.05). Changes in intracellular bicarbonate and lactate appeared to account in part for the observed stability of the liver pHi despite acute manipulations resulting in a range of pH values between 7.09 and 7.63 in arterial blood.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 34325     DOI: 10.1152/ajprenal.1979.236.3.F240

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.

Authors:  Shih-Chia Tso; Mingliang Lou; Cheng-Yang Wu; Wen-Jun Gui; Jacinta L Chuang; Lorraine K Morlock; Noelle S Williams; R Max Wynn; Xiangbing Qi; David T Chuang
Journal:  J Med Chem       Date:  2017-01-31       Impact factor: 7.446

2.  In vivo assessment of intracellular redox state in rat liver using hyperpolarized [1-13 C]Alanine.

Authors:  Jae Mo Park; Chalermchai Khemtong; Shie-Chau Liu; Ralph E Hurd; Daniel M Spielman
Journal:  Magn Reson Med       Date:  2017-03-05       Impact factor: 4.668

3.  Effects of dichloroacetate in the treatment of hypoxic lactic acidosis in dogs.

Authors:  H Graf; W Leach; A I Arieff
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

4.  An Acidic Environment Induces APOL1-Associated Mitochondrial Fragmentation.

Authors:  DengFeng Li; James A Snipes; Mariana Murea; Anthony J A Molina; Jasmin Divers; Barry I Freedman; Lijun Ma; Snezana Petrovic
Journal:  Am J Nephrol       Date:  2020-08-31       Impact factor: 3.754

5.  Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.

Authors:  Prashant Karki; Sayed Golam Mohiuddin; Pouria Kavousi; Mehmet A Orman
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

6.  Treatment of lactic acidosis with dichloroacetate in dogs.

Authors:  R Park; A I Arieff
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

7.  Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase.

Authors:  Arseniy Butrin; Anastassiya Butrin; Zdzislaw Wawrzak; Graham R Moran; Dali Liu
Journal:  J Biol Chem       Date:  2022-04-20       Impact factor: 5.486

8.  An In Vitro Whole-Organ Liver Engineering for Testing of Genetic Therapies.

Authors:  Maëlle Lorvellec; Alessandro Filippo Pellegata; Alice Maestri; Chiara Turchetta; Elena Alvarez Mediavilla; Soichi Shibuya; Brendan Jones; Federico Scottoni; Dany P Perocheau; Andrei Claudiu Cozmescu; Juliette M Delhove; Daniel Kysh; Asllan Gjinovci; John R Counsell; Wendy E Heywood; Kevin Mills; Tristan R McKay; Paolo De Coppi; Paul Gissen
Journal:  iScience       Date:  2020-11-13

9.  Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors.

Authors:  Keith T Schmidt; Alwin D R Huitema; Thomas P C Dorlo; Cody J Peer; Lisa M Cordes; Linda Sciuto; Susan Wroblewski; Yves Pommier; Ravi A Madan; Anish Thomas; William D Figg
Journal:  Cancer Chemother Pharmacol       Date:  2020-09-08       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.